Mutations in the photoreceptor-specific protein peripherin/rds are associated with multiple retinal diseases. To date, attempts to achieve complete structural and functional rescue in animal models of peripherin/rds-induced retinal degeneration have not been successful. Gene therapy-directed approaches have been hindered by the haploinsufficiency phenotype, which dictates well-regulated expression of peripherin/rds protein levels.
P eripherin/rds (P/rds) is an integral membrane glycoprotein distributed along the disc rim region of rod and cone outer segments (OS) as well as adjacent to the connecting cilium at the site of disc morphogenesis. 1, 2 Previous studies have highlighted its necessity in disc assembly, orientation, and physical stability and its suggested role in photoreceptor renewal. [2] [3] [4] Valuable insight into the structural role of P/rds has been provided by the retinal degeneration slow (rds) mouse, 5 in which a lack of endogenous P/rds protein leads to aberrant OS morphogenesis, followed by late-onset retinal degeneration. 6 -9 P/rds associates noncovalently with its nonglycosylated homologue Rom-1, 10 -13 and in vivo and in vitro studies have shown that these interactions result in the formation of homomeric and heteromeric core complexes.
14 These complexes play a crucial role in the maintenance of OS structural integrity. However, the difference in severity of phenotype between rds null mutant 6 -9 and Rom-1 knockout mice 15 indicates a primary and more critical role for P/rds in disc morphogenesis and maintenance.
More than 80 mutations in P/rds have been associated with retinal disease, 70% of which are single-point mutations with the remainder likely leading to a failure in protein expression. 16 The expressed phenotypes caused by these mutations in humans are heterogeneous, including retinitis pigmentosa and cone-rod dystrophy, among others. [17] [18] [19] [20] The rds and transgenic mouse models have been instrumental in studying the function of P/rds and the disease pathogenesis caused by its loss or mutation. 1, 13, [21] [22] [23] These models have provided an experimental system for testing therapeutic interventions for the treatment of retinal disease associated with expression of mutant forms of P/rds. 24 -27 In terms of therapy, P/rds poses a particular challenge because of a phenotype of haploinsufficiency associated with inadequate expression of the protein. 23 In the present study, we addressed two main subjects related to P/rds expression in rods and cones. First, we evaluated the critical levels of P/rds expression needed for short-and longterm maintenance of OS structure and function. Second, from a therapeutic application perspective, we assessed the effects of uniform P/rds overexpression on retinal morphology and ERG function. To perform our investigations, we generated transgenic mice carrying wild-type P/rds and mated them to rds Ϫ/Ϫ mice to modulate rod and cone P/rds levels.
MATERIALS AND METHODS

Generation of Transgenic Mice Expressing Normal Mouse P/rds
The transgene, a 1.6-kb full-length mouse P/rds cDNA, was directed to rods and cones by a 1.3-kb fragment of the human interphotoreceptor retinoid binding protein (hIRBP) promoter and included a 0.9-kb SV40 small t-intron and a polyA signal. The hIRBP promoter has been shown to direct efficient transgene expression to both rod and cone photoreceptors in mice. 28 -30 Transgenic mice were generated as described
Scotopic and Photopic Electroretinography
ERG testing was performed as described. 32 In brief, dark-adapted mice were administered an intramuscular injection of 85 mg/kg ketamine (Fort Dodge Animal Health; Fort Dodge, IA) and 14 mg/kg xylazine (The Butler Company; Columbus, OH). After anesthesia, vibrissae were trimmed and the eyes were dilated with 2.5% phenylephrine (Akorn, Inc., Decatur, IL). Electroretinograms (ERGs) were recorded with a stainless steel wire contacting the corneal surface through a layer of 2.5% methylcellulose, and animals were placed on a regulated heating pad throughout the experiment. Needle electrodes in the cheek and tail of the animals served as reference and ground leads, respectively. Responses were differentially amplified (half bandpass, 1-4000 Hz), averaged, and stored with signal averaging system (Compact 4; Nicolet Instrument Corp., Madison, WI). For the assessment of rod photoreceptor function (scotopic ERG), a strobe flash stimulus was presented to the dark-adapted, dilated eyes in the Ganzfeld (GS-2000; Nicolet Instrument Corp.) with a 137-cd ⅐ s/m 2 ) flash intensity. The amplitude of the a-wave was measured from the prestimulus baseline to the a-wave trough, whereas the amplitude of the b-wave was measured from the a-wave trough to the b-wave peak. For evaluation of cone function (photopic ERG), animals were light adapted for 5 minutes under a light intensity of 29.0285 cd/m 2 . A strobe flash stimulus was presented to the light-adapted, dilated eyes in the Ganzfeld with a 77-cd ⅐ s/m 2 ) flash intensity. The amplitude of the cone b-wave was measured from the a-wave trough to the b-wave peak.
Analysis of variance (ANOVA) and post hoc statistical tests using Bonferroni's pair-wise comparisons were used to determine the significance of differences in ERG responses (Prism ver. 3.02; GraphPad, San Diego, CA).
Histology at the Light and Electron Microscopy Level
Enucleated eyes were fixed and sectioned as described. 33 After sacrifice, the superior cornea was marked with a flaming needle before enucleation and a slit was made posterior to the cornea before a 1 hour fixation in freshly prepared 0.1 M sodium phosphate buffer (pH 7.4), containing 2.5% glutaraldehyde, 2.0% paraformaldehyde, and 0.025% CaCl 2 . The cornea and lens were then removed, and fixation was continued overnight. Fixed eyecups were rinsed twice for 10 minutes each in 0.1 M sodium cacodylate buffer (pH 7.4), containing 0.025% CaCl 2 , postfixed for 1 hour in 1% OsO 4 in 0.1 M sodium cacodylate, at room temperature, in the dark, then rinsed twice in cacodylate buffer and once in distilled water (DW).
Eyecups were dehydrated through a graded ethanol series followed by propylene oxide, infiltrated for 24 hours with Spurr resin, embedded in BEEM capsules (Beem Company, Bronx, NY) and polymerized at 70°C for 48 hours. Sectioning was performed on a microtome (Ultracut E; Reichert-Jung, Vienna Austria) equipped with glass and diamond (Diatome, Biel, Switzerland) knives. Semithin (0.75 m) sections were stained with 1% toluidine blue in 1% sodium borate. Thin (silver) sections were collected on copper 75/300 mesh grids, poststained with 2% uranyl acetate (aqueous) and lead citrate (Reynolds), and photographed by electron microscope (100CX; JEOL, Tokyo, Japan) at an accelerating voltage of 60 kV. Sections were viewed and photographed with a photomicroscope (BH-2; Olympus Corp. of America, Lake Success, NY) in the autoexpose mode, using 20ϫ or 60ϫ objectives.
Immunofluorescence Labeling
Enucleated eyes were fixed as previously described 23 and evaluated using anti-P/rds mAb 3B6 (1:5; Robert Molday, University of British Columbia, Vancouver, BC, Canada) and anti-human-blue opsin (1:3000; Jeremy Nathans, Johns Hopkins University, Baltimore, MD). 34 The anti-P/rds mAb 3B6 has the ability to exclusively recognize C-terminalmodified, but not endogenous, P/rds protein. Sections were incubated overnight at 4°C with primary antibodies followed by three phosphatebuffered saline (PBS) rinses, incubation with biotinylated FITC secondary antibody (1:100, 30 minutes), and finally three PBS washes. Images were captured with either an epifluorescence (Axioscope; Carl Zeiss Meditec, Jena, Germany) or a confocal (Leica TCS Sp2; Leica Microsystems, Wetzlar, Germany) microscope.
Immunoprecipitation and Immunoblot Analysis
Rabbit polyclonal antibodies against residues 331-346 and 336-351 of the P/rds (rds-C-term Ab) and Rom-1 carboxyl termini (Rom-1-C-term Ab), respectively, were used for immunoprecipitation (IP) and immunoblot analyses. The polyclonal anti-P/rds antibody has the ability to recognize both endogenous and the C-terminal-modified P/rds. Dissected retinas were homogenized on ice, solubilized for 1 hour at 4°C in solubilization buffer (50 mM Tris-HCl, [pH 7.5], 100 mM NaCl, 5 mM EDTA, 1% Triton X-100, 0.05% SDS, 2.5% glycerol, and 1.0 mM phenylmethylsulfonyl fluoride), and centrifuged at 100,000g for 30 minutes. The supernatants were collected for determination of protein concentration, IP, and immunoblot analyses. For IP, retinal extracts (200 g protein) were incubated in solubilization buffer with polyclonal anti-P/rds antibody (1:100 dilution) or anti-Rom-1 antibody (1: 100) and protein A-Sepharose beads (Sigma-Aldrich, St. Louis, MO) in a volume of 200 L at 4°C for 4 hours. After adsorption, the beads were washed with solubilization buffer three times (500 L for each wash), and bound proteins were eluted with 2ϫ sample buffer, followed by gel electrophoresis and immunoblot with anti-P/rds or anti-Rom-1 antibodies.
RESULTS
NMP Transgenic Protein Expression and Localization
To exclusively recognize the NMP product by mAb 3B6, we introduced a P341Q modification into the transgene. 2 Glutamine at position 341 is the only residue of the 3B6 antigenic site shared by human, bovine, and rat P/rds, but replaced by a proline in the mouse. This modification was performed by oligonucleotide-directed mutagenesis (CCG3 CAA).
Seven NMP lines were generated and characterized for site of integration, level of expression, and localization of the transgene product. The highest expresser was used to conduct all experiments described in this study. NMP mice were crossed onto an rds Ϫ/Ϫ background to quantify transgenic protein levels. Polyclonal anti-P/rds antibody, which recognizes both transgenic and endogenous proteins, was used to detect P/rds. No P/rds signal was found in the retinas of rds Ϫ/Ϫ mice (Fig.  1A, left) . Densitometric analysis of four independent immunoblots revealed the level of NMP protein obtained from homozygous retinas in the rds Ϫ/Ϫ background to be ϳ60% of wild-type P/rds (Fig. 1A, right) . Actin was used as an internal control and showed comparable levels in all samples examined (Fig. 1A,  left) . Figure 1B , top, demonstrates the ability of the mAb 3B6 to recognize only rat and NMP protein, but not mouse P/rds. Double-labeling with mAb 3B6 and anti-blue opsin antibody confirmed the presence of NMP protein in cone OS (Fig. 1B , overlay in the bottom panel). Labeling was restricted to the OS and no immunofluorescent signal was detected in other retinal layers. Laser deconvolution microscopy ( Fig. 1C ) was used to demonstrate appropriate localization of the NMP protein in OS disc rim regions. Double-staining with mAb 3B6 and anti-blue
Critical Peripherin/rds Levels 2515 opsin antibodies confirms localization of NMP to cone OS rims (Fig. 1C, overlay) .
Biochemical Properties of the NMP Protein
To evaluate the effect of the C-terminal P341Q modification on the characteristics of the protein, Western blot analysis was performed under reducing and nonreducing conditions using retinal extracts from NMP ϩ/ϩ /rds Ϫ/Ϫ and wild-type mice. Blots were then probed with P/rds and Rom-1 antibodies ( Fig. 2A) . Under reducing conditions, the major P/rds band migrated at the expected monomer position (ϳ36 kDa) 35 with a small portion at the dimer position (ϳ70 kDa) in retinal samples Under reducing conditions, the major band of P/rds (top left) migrated as a monomer, with lesser amounts corresponding to the dimer also detected, whereas Rom-1 migrated as a monomer (lower left) in retinal samples from both NMP and wild-type mice. Under nonreducing conditions, dimer and higher-order oligomers of P/rds (top right) and Rom-1 (bottom right) were predominant. (B) Reciprocal Co-IP using anti-P/rds (top) and anti-Rom-1 (bottom) antibodies showing a comparable pattern of association between P/rds and Rom-1 in both NMP and wild-type retinas, indicating that the NMP protein is able to interact with Rom-1. Retinal samples from rds Ϫ/Ϫ mice were included as a negative control.
from both NMP and wild-type mice ( Fig. 2A, top left) . Under nonreducing conditions, dimers and higher-order oligomers were detected in both types of retinas ( Fig. 2A, top right) . Appearance of the dimer form of P/rds under reducing conditions reflects an incomplete reduction of the protein. No P/rds signal was detected in retinal extracts from rds Ϫ/Ϫ mice. The comparable migration pattern of the NMP protein under both reducing and nonreducing conditions suggests that the P341Q modification in NMP has no effect on the ability of the protein to form dimers and higher-order oligomers.
We examined the expression and migration patterns of Rom-1 under reducing and nonreducing conditions from NMP retinas. Under reducing conditions, Rom-1 migrated as a monomer (ϳ36 kDa) 11 in retinal samples from both wild-type and NMP ϩ/ϩ /rds Ϫ/Ϫ mice ( Fig. 2A, bottom left) . Under nonreducing conditions, monomers, dimers and higher-order forms of Rom-1 were observed ( Fig. 2A, bottom right) . The migration pattern of Rom-1 in NMP retinal extracts was similar to that observed in wild-type extracts, indicating a lack of negative effect of the P341Q modification on Rom-1 expression. Moreover, levels of Rom-1 in rds Ϫ/Ϫ retinal extracts were significantly reduced compared with that in both wild-type and NMP extracts ( Fig. 2A, bottom) , suggesting that the expression or stability of Rom-1 is dependent on the presence of P/rds and is restored in the presence of NMP protein.
The association between P/rds and Rom-1 was further assessed by reciprocal co-IP analysis. The similarity in pattern of association between wild-type and NMP ϩ/ϩ /rds Ϫ/Ϫ retinas suggests that the P341Q modification does not alter the ability of P/rds to interact with Rom-1 (Fig. 2B) . Retinal samples from rds Ϫ/Ϫ mice were included as a negative control (Fig. 2B ).
NMP Protein Mediates Functional and Structural Rescue of the rds ؊/؊ Retina
To test the ability of the NMP protein to build and maintain OS in the absence of endogenous P/rds, homozygous NMP mice were generated in an rds Ϫ/Ϫ background. In the absence of endogenous P/rds, rds Ϫ/Ϫ mice show no scotopic or photopic ERG response (Figs. 3A-C) . Scotopic a-wave amplitudes correlated positively with P/rds levels in NMP ϩ/ϩ /rds Ϫ/Ϫ and rds ϩ/Ϫ mice, exhibiting a proportionate restoration of rod function (Figs. 3A, 3B ). At this age, no differences in cone function were detected between NMP ϩ/ϩ /rds Ϫ/Ϫ and rds ϩ/Ϫ mice; both groups showed photopic b-wave amplitudes comparable to those of wild-type mice (Fig. 3C) . Structurally, NMP ϩ/ϩ /rds Ϫ/Ϫ retinas (60% of wild type) showed disorganized and swirl-like OS formation at the EM level, albeit to a lesser degree than that in rds ϩ/Ϫ retinas (50% of wild type) and contained relatively more OS material than did rds ϩ/Ϫ retinas (data not shown). This finding correlates well with the addi- 
Critical Level of P/rds Needed to Maintain Photoreceptor Structure and Function
Because haploinsufficiency phenotype associates with the loss of one P/rds allele, 23 we assessed the critical level of P/rds (in excess of 50%) necessary to maintain OS morphology and function. NMP ϩ/Ϫ animals were generated on an rds ϩ/Ϫ background, with a total amount of P/rds equivalent to 80% of wild type. These animals were evaluated for resolution of functional and structural defects in rds ϩ/Ϫ mice. The 30% increase in P/rds in 1-month-old NMP ϩ/Ϫ /rds ϩ/Ϫ relative to age-matched rds ϩ/Ϫ retinas was evident by blot analysis (Fig. 4A) . At this age, NMP ϩ/Ϫ /rds ϩ/Ϫ mice showed scotopic and photopic ERG amplitudes comparable to those of wild-type mice and were considerably improved when compared with rds ϩ/Ϫ mice (data not shown). To assess the long-term impact of this level mice were examined at 7 months of age. A significant increase (P Ͻ 0.001) was detected in scotopic a-wave amplitudes, indicating improved rod function relative to age-matched rds ϩ/Ϫ mice (Fig. 4B) . Furthermore, improvement in photopic ERG responses was also significant (P Ͻ 0.05) in NMP ϩ/Ϫ / rds ϩ/Ϫ mice relative to rds ϩ/Ϫ (Fig. 4C) . The enhancement in retinal function afforded by the increase in P/rds was also detected on a structural level. Retinal histology showed a considerable improvement in OS structure and length in NMP ϩ/Ϫ /rds ϩ/Ϫ transgenics when compared with rds ϩ/Ϫ mice (Fig. 4D, top) . This amelioration of OS integrity was accompanied by a preservation of two to three rows of photoreceptor nuclei. Examination of these retinas by EM confirmed the marked ultrastructural rescue of OSs (Fig. 4D , bottom). When compared with the swirl-like OSs in rds ϩ/Ϫ retinas (50% of wild-type), exacerbated at 7-months of age, NMP ϩ/Ϫ / rds ϩ/Ϫ retinas (80% of wild type) showed a remarkable, although incomplete, restoration of OS alignment and structure (Fig. 4D, bottom) .
Effects of P/rds Overexpression
To determine the effects of P/rds overexpression on retinal function and structure, animals homozygous for the NMP transgene were generated on a wild-type P/rds background (NMP ϩ/ ϩ/ϩ/ϩ). Blot analysis (Fig. 5A ) revealed ϳ45% to 50% overexpression of P/rds above wild type. Retinal ERG function was first evaluated at 1 month and its assessment continued up to 7ϩ months of age in mice overexpressing P/rds. Scotopic (Fig.  5B) and photopic (Fig. 5C ) ERG wave amplitudes were not significantly altered in NMP ϩ/ϩ /ϩ/ϩ mice, compared with age-matched wild-type mice. Concomitantly, no histologic abnormalities were found in retinas of 4-month-old mice overexpressing P/rds (Fig. 5D, top) . At light and EM levels, no histologic or ultrastructural abnormalities or loss of photoreceptors were detected in NMP ϩ/ϩ /ϩ/ϩ mice (Fig. 5D ).
DISCUSSION
The loss of one allele of P/rds has been described to correlate with a haploinsufficiency phenotype, which presents with an abnormality in OS morphology and an early-onset deficiency in rod function, followed by a decline in cone function and a slow rate of photoreceptor degeneration. 23 Since then, studies have attempted to define more clearly the intermediate levels (50%-100%) of P/rds required to sustain rod photoreceptor function. 13, 27 The present study complements previous findings as the first to address the differential effects of P/rds modulation on both rod and cone photoreceptors in vivo. Transgenic mice expressing a modified wild-type mouse P/rds were used to evaluate the critical level of P/rds necessary for short-and long-term maintenance of OS structure and function. Moreover, we systematically evaluated the effects of P/rds overexpression on both photoreceptor cell types. We distinguished between the transgenic and endogenous proteins by C-terminal modification (P341Q), which allowed for exclusive recognition of the transgene product by mAb 3B6 and confirmed appropriate localization of the NMP protein to both rod and cone photoreceptor discs. 2 Biochemically, the transgenic protein was shown to interact with itself as well as with Rom-1 in a pattern identical with the endogenous P/rds protein.
Levels of P/rds resulting from each NMP transgenic allele equated to 60% of one wild-type allele. In the absence of endogenous P/rds, mice homozygous for the NMP transgene (60% of wild-type) were able to build OSs and recover ϳ60% of rod function when compared with rds Ϫ/Ϫ mice. Relative to rds ϩ/Ϫ retinas (50% of wild-type), NMP ϩ/ϩ /rds Ϫ/Ϫ retinas showed an improvement in OS structure and rod function, positively correlating with the 10% increase in P/rds level. In agreement with our previous findings, 23 we also observed that, unlike rods, cones are able to retain wild-type levels of ERG function at an early age with as little as 50% P/rds protein. It is likely that structural differences between rods and cones, in particular shorter OS length and continuous disc membrane structure of cones, account for this finding. We showed that 80% of wild-type P/rds was sufficient to support both normal rod and cone ERG amplitudes and normal OS structures, when compared with rds ϩ/Ϫ retinas (50% of wild-type). In the long term, NMP ϩ/Ϫ /rds ϩ/Ϫ (80% of wild-type) retinas showed a remarkable ability to maintain OS morphology, despite infrequent abnormalities, accompanied by significantly improved rod function, compared with rds ϩ/Ϫ retinas which showed gross abnormality in OS structure and dramatically reduced rod function. Early on only a 50% level of P/rds is necessary for cone function, and its declines with age. This reduction in cone function may be attributed to the previously suggested cone-rod interdependence. 36 It is worthwhile to note that, at 7 months of age, the 30% increase in P/rds expression afforded by the addition of one allele of the NMP transgene to the rds ϩ/Ϫ retina not only improved rod function, but more important, it prevented age-dependent deterioration in cone photoreceptor function. This is of particular clinical significance in halting the progression of cone degeneration in cases of macular disease. These results also agree with the hypothesis that prolonging rod survival leads to a prolonged survival of cones. 37, 38 A pertinent issue the design of therapeutic strategies for the treatment of P/rds-associated retinal diseases is the effect of P/rds overexpression on photoreceptor structure and function. Using NMP transgenics, we overexpressed P/rds in rods and cones at a level 50% above wild type. Overexpression of P/rds has been suggested by Sarra et al. 26 to be detrimental to photoreceptor survival. However, neither quantitation of P/rds overexpression nor immunohistochemical evidence linking virally mediated expression of P/rds with retinal cell death was provided by that study. Although overexpression of opsin has been shown to induce photoreceptor cell death, 33 in our study, this was not the case for P/rds. We ensured uniform overexpression of P/rds in both rods and cones and showed that additional P/rds protein causes neither functional nor structural defects up to 7 months of age, the latest time examined.
In summary, this study is the first to define comprehensively the critical levels of P/rds needed in vivo to maintain long-term OS structure and function, as well as to demonstrate the lack of detectable deleterious effects resulting from P/rds overexpression. These findings are likely to be of value in development of gene therapy interventions in P/rds-associated retinal disease.
